跳至主要内容
临床试验/NCT00542256
NCT00542256已完成不适用

Effects of Transcranial DC Stimulation Coupled With Constraint Induced Movement Therapy on Motor Function in Stroke Patients

Beth Israel Deaconess Medical Center2 个研究点 分布在 1 个国家目标入组 85 人开始时间: 2007年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
85
试验地点
2
主要终点
Motor Activity Log Rating Scale

研究概览

简要总结

The purpose of this study is to determine whether a painless and noninvasive procedure called transcranial direct current stimulation (tDCS) combined with a method of physical therapy called constraint-induced movement therapy improves motor function in patients with chronic stroke. Research in healthy subjects has shown that when tDCS is combined with motor learning tasks, there is an increase in learning as compared to motor learning tasks only. The tDCS procedure sessions will be compared to sham (fake) procedure sessions, which is also called placebo stimulation. This study is double blind, which means neither the subjects nor researchers analyzing motor function will know if participants are receiving real tDCS stimulation or placebo. Only the person performing the procedure will know which one participants are receiving. Only by comparing the tDCS procedure to a sham (placebo) procedure can we understand if the tDCS actually improves motor function.

We hypothesize that tDCS will enhance the effects of constraint-induced movement therapy on motor recovery in chronic stroke patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • First time clinical ischemic or hemorrhagic cerebrovascular accident (radiologically confirmed)
  • Demonstrates adequate balance while wearing a hand restraint on the unaffected arm
  • Ability to stand from a sitting position and ability to stand with or without upper extremity support
  • Stroke onset at least 6 months prior to study enrollment

排除标准

  • Significant pre-stroke disability
  • Any substantial decrease in alertness, language reception, or attention that might interfere with understanding instructions for motor testing
  • Excessive pain in any joint of the paretic extremity
  • A terminal medical diagnosis consistent with survival of less than 1 year
  • Advanced liver, kidney, cardiac, or pulmonary disease
  • Coexistent major neurological or psychiatric disease (including epilepsy)
  • A history of significant alcohol or drug abuse in the prior 3 years
  • Use of neuropsychotropic drugs - such as antidepressants
  • Patients may not be actively enrolled in a separate intervention study targeting stroke recovery
  • Patients may not have already received constraint-induced movement therapy and/or tDCS treatment for stroke

结局指标

主要结局

Motor Activity Log Rating Scale

时间窗: Baseline, Treatment Days 1,5,10 and Follow Up

Jebsen-Taylor Hand Function Test

时间窗: Baseline, Treatment days 1,5,10, Follow Up

Beck Depression Inventory

时间窗: Baseline, Treatment days 1,5,10 and Follow up

Visual Analogue Scale for Anxiety

时间窗: Baseline, Treatment days 1,5,10 and Follow Up

次要结局

  • Fugl Meyer Assessment of Motor Recovery(Baseline Assessment)
  • Modified Ashworth Scale(Baseline Assessment)
  • Barthel Index Score(Baseline Assessment)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Felipe Fregni

Study Principal Investigator

Beth Israel Deaconess Medical Center

研究点 (2)

Loading locations...

相似试验